Načítá se...
Pharmacogenomics of intracellular methotrexate polyglutamates in patients’ leukemia cells in vivo
BACKGROUND: Interpatient differences in the accumulation of methotrexate’s active polyglutamylated metabolites (MTXPGs) in leukemia cells influence its antileukemic effects. METHODS: To identify genomic and epigenomic and patient variables determining the intracellular accumulation of MTXPGs, we mea...
Uloženo v:
| Vydáno v: | J Clin Invest |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Clinical Investigation
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7685728/ https://ncbi.nlm.nih.gov/pubmed/33164984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI140797 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|